Related references
Note: Only part of the references are listed.Change of procalcitonin predicts clinical outcome of febrile episodes in patients with hematological malignancies
M. von Lilienfeld-Toal et al.
SUPPORTIVE CARE IN CANCER (2006)
Procalcitonin and neopterin correlation with aetiology and severity of pneumonia
C Prat et al.
JOURNAL OF INFECTION (2006)
Prospective evaluation of procalcitonin in adults with non-neutropenic fever after allogeneic hematopoietic stem cell transplantation
M Ortega et al.
BONE MARROW TRANSPLANTATION (2006)
Risk assessment and treatment of low-risk patients with febrile neutropenia
WV Kern
CLINICAL INFECTIOUS DISEASES (2006)
Biomarkers of sepsis: clinically useful?
M Meisner
CURRENT OPINION IN CRITICAL CARE (2005)
Interleukin-8 serum levels at fever onset in patients with neutropenia predict early medical complications
A Engel et al.
INFECTION (2005)
Phase I evaluation of a 40-kDa branched-chain long-acting pegylated IFN-α-2a with and without cytarabine in patients with chronic myelogenous leukemia
M Talpaz et al.
CLINICAL CANCER RESEARCH (2005)
Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia
L Persson et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2005)
Prospective evaluation of procalcitonin in adults with febrile neutropenia after haematopoietic stem cell transplantation
M Ortega et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia:: experience from a multicentre study
H Giamarellou et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Procalcitonin and C-reactive protein do not discriminate between febrile reaction to anti-T-lymphocyte antibodies and Gram-negative sepsis
HJ Dornbusch et al.
BONE MARROW TRANSPLANTATION (2003)
Procalcitonin, C-reactive protein and leukocyte count in children with lower respiratory tract infection
C Prat et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2003)
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
WT Hughes et al.
CLINICAL INFECTIOUS DISEASES (2002)
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus
S Ascioglu et al.
CLINICAL INFECTIOUS DISEASES (2002)
Massive elevation of procalcitonin plasma levels in the absence of infection in kidney transplant patients treated with pan-T-cell antibodies
R Sabat et al.
INTENSIVE CARE MEDICINE (2001)
Clinical value of serial measurement of serum C-reactive protein level in neutropenic patients
K Yonemori et al.
LEUKEMIA & LYMPHOMA (2001)
Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II
G Fleischhack et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)